Qilu Pharm Hainan Company Profile
What is the competitive landscape for QILU PHARM HAINAN
QILU PHARM HAINAN has twenty-one approved drugs.
Drugs and US Patents for Qilu Pharm Hainan
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qilu Pharm Hainan | GEFITINIB | gefitinib | TABLET;ORAL | 211591-001 | Feb 13, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Qilu Pharm Hainan | PALONOSETRON HYDROCHLORIDE | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 205648-002 | Sep 19, 2018 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Qilu Pharm Hainan | MICAFUNGIN SODIUM | micafungin sodium | INJECTABLE;INTRAVENOUS | 219273-001 | Apr 3, 2025 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Qilu Pharm Hainan | DOXORUBICIN HYDROCHLORIDE | doxorubicin hydrochloride | INJECTABLE, LIPOSOMAL;INJECTION | 219881-001 | Feb 3, 2026 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Qilu Pharm Hainan | PEMETREXED DISODIUM | pemetrexed disodium | POWDER;INTRAVENOUS | 204890-002 | May 25, 2022 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

